AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-85
Results: 1-25/85
REDUCED ISLET AMYLOID POLYPEPTIDE RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM
Authors: KAHN SE VERCHERE CB ANDRIKOPOULOS S ASBERRY PJ LEONETTI DL BOYKO EJ SCHWARTZ RS AUSTIN MA FUJIMOTO WY
Citation: Se. Kahn et al., REDUCED ISLET AMYLOID POLYPEPTIDE RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM, Journal of investigative medicine, 46(1), 1998, pp. 92-92
HUMAN AGING IS ASSOCIATED WITH PARALLEL REDUCTIONS IN INSULIN AND AMYLIN RELEASE
Authors: DECHENES CJ VERCHERE CB ANDRIKOPOULOS S KAHN SE
Citation: Cj. Dechenes et al., HUMAN AGING IS ASSOCIATED WITH PARALLEL REDUCTIONS IN INSULIN AND AMYLIN RELEASE, American journal of physiology: endocrinology and metabolism, 38(5), 1998, pp. 785-791
EFFECT OF TROGLITAZONE ON B-CELL FUNCTION, INSULIN SENSITIVITY, AND GLYCEMIC CONTROL IN SUBJECTS WITH TYPE-2 DIABETES-MELLITUS
Authors: PRIGEON RL KAHN SE PORTE D
Citation: Rl. Prigeon et al., EFFECT OF TROGLITAZONE ON B-CELL FUNCTION, INSULIN SENSITIVITY, AND GLYCEMIC CONTROL IN SUBJECTS WITH TYPE-2 DIABETES-MELLITUS, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 819-823
DISPROPORTIONATELY ELEVATED PROINSULIN LEVELS REFLECT THE DEGREE OF IMPAIRED B-CELL SECRETORY CAPACITY IN PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS
Authors: RODER ME PORTE D SCHWARTZ RS KAHN SE
Citation: Me. Roder et al., DISPROPORTIONATELY ELEVATED PROINSULIN LEVELS REFLECT THE DEGREE OF IMPAIRED B-CELL SECRETORY CAPACITY IN PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 604-608
REDUCED AMYLIN RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND TYPE-2 DIABETES IN JAPANESE-AMERICANS
Authors: KAHN SE VERCHERE CB ANDRIKOPOULOS S ASBERRY PJ LEONETTI DL WAHL PW BOYKO EJ SCHWARTZ RS NEWELLMORRIS L FUJIMOTO WY
Citation: Se. Kahn et al., REDUCED AMYLIN RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND TYPE-2 DIABETES IN JAPANESE-AMERICANS, Diabetes, 47(4), 1998, pp. 640-645
ROLE OF APOLIPOPROTEIN-E AND PERLECAN IN ISLET AMYLOID FORMATION IN TRANSGENIC MICE EXPRESSING HUMAN ISLET AMYLOID POLYPEPTIDE
Authors: VERCHERE CB ANDRIKOPOULOS S DALESSIO DA OBRIEN KD WIGHT TN SNOW AD OLIN KL CHAIT A KAHN SE
Citation: Cb. Verchere et al., ROLE OF APOLIPOPROTEIN-E AND PERLECAN IN ISLET AMYLOID FORMATION IN TRANSGENIC MICE EXPRESSING HUMAN ISLET AMYLOID POLYPEPTIDE, Diabetes, 47, 1998, pp. 117-117
ESTROGEN REPLACEMENT THERAPY IS ASSOCIATED WITH A REDUCTION IN DISPROPORTIONATE PROINSULINEMIA IN POSTMENOPAUSAL JAPANESE-AMERICAN WOMEN
Authors: KAHN SE LEONETTI DL BOYKO EJ NEWELL LL FUJIMOTO WY
Citation: Se. Kahn et al., ESTROGEN REPLACEMENT THERAPY IS ASSOCIATED WITH A REDUCTION IN DISPROPORTIONATE PROINSULINEMIA IN POSTMENOPAUSAL JAPANESE-AMERICAN WOMEN, Diabetes, 47, 1998, pp. 607-607
COMPARISON OF ESTIMATES OF INSULIN SENSITIVITY AND B-CELL FUNCTION DERIVED FROM THE ORAL GLUCOSE-TOLERANCE TEST VERSUS THE INTRAVENOUS GLUCOSE-TOLERANCE TEST AND MINIMAL MODEL
Authors: HOWELL WM PRIGEON RL FUJIMOTO WY KAHN SE
Citation: Wm. Howell et al., COMPARISON OF ESTIMATES OF INSULIN SENSITIVITY AND B-CELL FUNCTION DERIVED FROM THE ORAL GLUCOSE-TOLERANCE TEST VERSUS THE INTRAVENOUS GLUCOSE-TOLERANCE TEST AND MINIMAL MODEL, Diabetes, 47, 1998, pp. 697-697
EVIDENCE FOR ISLET AMYLOID FIBRIL FORMATION IN A NEW MOUSE MODEL OF INSULINOMA PRODUCING AND SECRETING HUMAN ISLET AMYLOID POLYPEPTIDE
Authors: ANDRIKOPOULOS S VERCHERE CB HOWELL WM WIGHT TN KAHN SE
Citation: S. Andrikopoulos et al., EVIDENCE FOR ISLET AMYLOID FIBRIL FORMATION IN A NEW MOUSE MODEL OF INSULINOMA PRODUCING AND SECRETING HUMAN ISLET AMYLOID POLYPEPTIDE, Diabetes, 47, 1998, pp. 763-763
AMYLIN RELEASE DECREASES IN PARALLEL WITH INSULIN RELEASE IN AGING
Authors: DECHENES C VERCHERE CB ANDRIKOPOULOS S KAHN SE
Citation: C. Dechenes et al., AMYLIN RELEASE DECREASES IN PARALLEL WITH INSULIN RELEASE IN AGING, Diabetes, 47, 1998, pp. 1551-1551
A NEW METHOD FOR PREDICTING INSULIN SENSITIVITY FROM ORAL GLUCOSE-TOLERANCE TEST-RESULTS
Authors: PRIGEON RL HOWELL WM KAHN SE
Citation: Rl. Prigeon et al., A NEW METHOD FOR PREDICTING INSULIN SENSITIVITY FROM ORAL GLUCOSE-TOLERANCE TEST-RESULTS, Diabetes, 47, 1998, pp. 1638-1638
EFFECT OF AGE, SEX, ORAL-CONTRACEPTIVES AND VITAMIN SUPPLEMENTS ON THE SERUM TOTAL HOMOCYSTEINE CONCENTRATION
Authors: CALLAS DD BERMES EW OESER T KAHN SE HOLMES EW
Citation: Dd. Callas et al., EFFECT OF AGE, SEX, ORAL-CONTRACEPTIVES AND VITAMIN SUPPLEMENTS ON THE SERUM TOTAL HOMOCYSTEINE CONCENTRATION, Clinical chemistry, 44, 1998, pp. 583-583
EVIDENCE THAT PLASMA LEPTIN AND INSULIN LEVELS ARE ASSOCIATED WITH BODY ADIPOSITY VIA DIFFERENT MECHANISMS
Authors: SCHWARTZ MW PRIGEON RL KAHN SE NICOLSON M MOORE J MORAWIECKI A BOYKO EJ PORTE D
Citation: Mw. Schwartz et al., EVIDENCE THAT PLASMA LEPTIN AND INSULIN LEVELS ARE ASSOCIATED WITH BODY ADIPOSITY VIA DIFFERENT MECHANISMS, Diabetes care, 20(9), 1997, pp. 1476-1481
ENDOGENOUS SOMATOSTATIN-28 MODULATES POSTPRANDIAL INSULIN-SECRETION IMMUNONEUTRALIZATION STUDIES IN BABOONS
Authors: ENSINCK JW VOGEL RE LASCHANSKY EC KOERKER DJ PRIGEON RL KAHN SE DALESSIO DA
Citation: Jw. Ensinck et al., ENDOGENOUS SOMATOSTATIN-28 MODULATES POSTPRANDIAL INSULIN-SECRETION IMMUNONEUTRALIZATION STUDIES IN BABOONS, The Journal of clinical investigation, 100(9), 1997, pp. 2295-2302
CANDIDATE GENES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: DEEB SS STONE LM KAHN SE FUJIMOTO WY LAAKSO M PORTE D
Citation: Ss. Deeb et al., CANDIDATE GENES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Atherosclerosis, 130, 1997, pp. 69-69
TRANSGENIC OVERPRODUCTION OF ISLET AMYLOID POLYPEPTIDE (AMYLIN) IS NOT SUFFICIENT FOR ISLET AMYLOID FORMATION
Authors: VERCHERE CB DALESSIO DA WANG S ANDRIKOPOULOS S KAHN SE
Citation: Cb. Verchere et al., TRANSGENIC OVERPRODUCTION OF ISLET AMYLOID POLYPEPTIDE (AMYLIN) IS NOT SUFFICIENT FOR ISLET AMYLOID FORMATION, Hormone and Metabolic Research, 29(6), 1997, pp. 311-316
REDUCED ISLET AMYLOID POLYPEPTIDE RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM
Authors: KAHN SE VERCHERE CB ANDRIKOPOULOS S ASBERRY PJ LEONETTI DL BOYKO EJ SCHWARTZ RS AUSTIN MA FUJIMOTO WY
Citation: Se. Kahn et al., REDUCED ISLET AMYLOID POLYPEPTIDE RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM, Diabetologia, 40, 1997, pp. 95-95
INTACT BUT NOT TRUNCATED DES(27-31) RAT C-PEPTIDE STIMULATES BETA-CELL NA-ATPASE ACTIVITY(,K+)
Authors: WAHREN J BERTORELLO A KAHN SE VERCHERE CB JOHANSSON BL HALBAN PA
Citation: J. Wahren et al., INTACT BUT NOT TRUNCATED DES(27-31) RAT C-PEPTIDE STIMULATES BETA-CELL NA-ATPASE ACTIVITY(,K+), Diabetologia, 40, 1997, pp. 585-585
RELEASE OF INCOMPLETELY PROCESSED PROINSULIN IS THE CAUSE OF THE DISPROPORTIONATE PROINSULINEMIA OF NIDDM
Authors: KAHN SE HALBAN PA
Citation: Se. Kahn et Pa. Halban, RELEASE OF INCOMPLETELY PROCESSED PROINSULIN IS THE CAUSE OF THE DISPROPORTIONATE PROINSULINEMIA OF NIDDM, Diabetes, 46(11), 1997, pp. 1725-1732
VALIDATION OF A 25-SAMPLE TOLBUTAMIDE-MODIFIED INTRAVENOUS GLUCOSE-TOLERANCE TEST TO PHENOTYPE SUBJECTS FOR GENETIC-STUDIES OF NIDDM
Authors: PRIGEON RL KAHN SE
Citation: Rl. Prigeon et Se. Kahn, VALIDATION OF A 25-SAMPLE TOLBUTAMIDE-MODIFIED INTRAVENOUS GLUCOSE-TOLERANCE TEST TO PHENOTYPE SUBJECTS FOR GENETIC-STUDIES OF NIDDM, Diabetes, 46, 1997, pp. 532-532
GENERATION OF A NEW BETA-CELL LINE SECRETING HUMAN ISLET AMYLOID POLYPEPTIDE
Authors: ANDRIKOPOULOS S VERCHERE CB TEAGUE JC BASKIN DG FUJIMOTO WY KAHN SE
Citation: S. Andrikopoulos et al., GENERATION OF A NEW BETA-CELL LINE SECRETING HUMAN ISLET AMYLOID POLYPEPTIDE, Diabetes, 46, 1997, pp. 813-813
GLYCOSYLATED AMYLIN IS SECRETED BY HUMAN ISLETS IN-VITRO
Authors: VERCHERE CB RITTENHOUSE J ANDRIKOPOULOS S KODA JE KAHN SE
Citation: Cb. Verchere et al., GLYCOSYLATED AMYLIN IS SECRETED BY HUMAN ISLETS IN-VITRO, Diabetes, 46, 1997, pp. 1358-1358
REDUCED AMYLIN RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM IN JAPANESE-AMERICANS
Authors: KAHN SE VERCHERE CB ANDRIKOPOULOS S ASBERRY PJ LEONETTI DL SCHWARTZ RS AUSTIN MA FUJIMOTO WY
Citation: Se. Kahn et al., REDUCED AMYLIN RELEASE IS A CHARACTERISTIC OF IMPAIRED GLUCOSE-TOLERANCE AND NIDDM IN JAPANESE-AMERICANS, Diabetes, 46, 1997, pp. 1373-1373
CLINICAL UTILITY OF CARDIAC TROPONIN-I MEASUREMENTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION AND IMPLEMENTATION OF THEIR USE IN AN ACADEMIC-MEDICAL-CENTER
Authors: KAHN SE WARD KA GALBRAITH KA CALLAS DD BANGAYAN L AUGUSTINE GA BERMES EW
Citation: Se. Kahn et al., CLINICAL UTILITY OF CARDIAC TROPONIN-I MEASUREMENTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION AND IMPLEMENTATION OF THEIR USE IN AN ACADEMIC-MEDICAL-CENTER, Clinical chemistry, 43, 1997, pp. 66-66
THE AGING-ASSOCIATED REDUCTION IN B-CELL FUNCTION DOES NOT INCLUDE DISPROPORTIONATE PROINSULINEMIA
Authors: RODER ME SCHWARTZ RS KAHN SE
Citation: Me. Roder et al., THE AGING-ASSOCIATED REDUCTION IN B-CELL FUNCTION DOES NOT INCLUDE DISPROPORTIONATE PROINSULINEMIA, Journal of investigative medicine, 44(1), 1996, pp. 112-112
Risultati: 1-25 | 26-50 | 51-75 | 76-85